LifeMD, Inc. — Director's Dealing 2021

Dec 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2019-09-30

Reporting Person: Velge Bertrand (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-15	Common Stock	P	294118	$0.17	Acquired	511509	Direct
2020-08-05	Common Stock	A	173234	—	Acquired	684743	Direct
2020-09-22	Common Stock	P	96923	$0.65	Acquired	781666	Direct
2021-12-03	Common Stock	P	110000	$3.91	Acquired	891666	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-30	Stock Option (Right to Buy)	$1.15	A	2500	Acquired	2024-09-30	Common Stock (2500)	Direct
2019-12-31	Stock Option (Right to Buy)	$1.15	A	2500	Acquired	2024-12-31	Common Stock (2500)	Direct
2020-03-31	Stock Option (Right to Buy)	$1.2	A	2500	Acquired	2025-03-31	Common Stock (2500)	Direct
2020-06-30	Stock Option (Right to Buy)	$1.5	A	2500	Acquired	2025-06-30	Common Stock (2500)	Direct
2020-09-22	Warrants to Purchase Common Stock	$4.65	A	100000	Acquired	2024-09-22	Common Stock (100000)	Direct
2020-09-30	Stock Option (Right to Buy)	$7.95	A	2500	Acquired	2025-09-30	Common Stock (2500)	Direct
2020-12-31	Stock Option (Right to Buy)	$7	A	2500	Acquired	2025-12-31	Common Stock (2500)	Direct
2021-03-31	Stock Option (Right to Buy)	$11.98	A	2500	Acquired	2026-03-31	Common Stock (2500)	Direct
2020-06-30	Stock Option (Right to Buy)	$11.56	A	2500	Acquired	2026-06-30	Common Stock (2500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	217391	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants to Purchase Common Stock	$0.28	2023-05-15	Common Stock (217391)	217391	Direct

Footnotes

F1: On October 14, 2020, the common stock of LFMD, Inc. had a reverse stock split 1-for-5, resulting in a decrease of the reporting person's ownership of 869,566 shares of common stock.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

F3: Issued in connection with Exchange Agreement dated September 22, 2020 whereby shares of common stock and warrants were exchanged for outstanding debt.

F4: Issued as director's compensation.

F5: Issued pursuant to anti-dilution provisions contained in the Securities Purchase Agreement dated May 31, 2019.